Japan Nanomedicine Society (JNS)

日本ナノメディシン交流協会

Purpose and Outline

Purpose of Establishment

The end of the 19th century and the beginning of the 20th century was the era of the big bang of modern science, with Thomson's discovery of the electron in 1897, Einstein's announcement of the special theory of relativity in 1905, and Born's announcement of quantum mechanics in 1924. Around 1950, these major inventions and discoveries in the basic sciences matured and blossomed, and there was a succession of major discoveries and inventions in applied sciences, such as the discovery of transistor operation by Brattain and Bourdain in 1947 and the invention of the laser by Townes and Shaulow, which led to the development of ultra-high density integrated circuits, and with these, the concept of nanotechnology was born. The concept of nanotechnology was born. This concept of nanotechnology evolved into the bottom-up concept of nanotechnology with the discovery of fullerenes and carbon nanotubes.
The emergence of nanotechnology is bringing about major changes in conventional medicine and medical care based on life sciences. The concept of material science-based medicine and medical treatment, i.e., nanomedicine, has emerged, including single molecule manipulation and molecular imaging using fluorescent probes, drug delivery using quantum dots, vesicles, and clusters, creation of novel biochips and biosensors by nanofabrication of substrate surfaces, and diagnosis and treatment using spectroscopy with nano-level spatial resolution. The concept of nanomedicine, i.e., medicine and medical treatment based on material science, has emerged.

It is important to recognize, however, that the term “nanomedicine” was used in the announcement of the Roadmap for Human Health by the NIH with the completion of the decoding of the human genome in April 2003. The discovery of the double helix by Watson and Crick triggered the birth of interdisciplinary fields such as biophysics, where life is studied from the perspective of material science, and the valley between life and material sciences has been illuminated day by day by the light of science through the efforts of many people. The speed of this change has become even more rapid with the decoding of the genome, and its impact has extended to almost all areas of science and technology.

In other words, nanomedicine is a concept born from the miracle of the completion of genome decoding, which demonstrated the principle that all structures and functions of life, and therefore medicine, can be solved on the basis of molecules, and the coincidental emergence of nanotechnology as a means to implement this principle.

This historical overview leads us to the science of molecules as the common ground for nanotechnology and DNA. The design and analysis of physical properties and functions of nanostructures and nanoparticles, not to mention genes and proteins, is a field of molecular science, and the contribution of molecular science to nanomedicine is clear. In addition, when we examine various diseases such as neurodegenerative diseases, cardiovascular diseases, and cancer, we should consider that the active contribution of molecular-level science is desired.

In this situation, nanomedicine has an unprecedentedly broad interdisciplinary nature, with related academic fields such as material science, life science, pharmaceutical science, medicine, related engineering, and diagnostic medicine, and even areas where there has been no academic exchange to date are intermingled. In order to achieve a significant contribution to society, it is extremely important to have a common forum for discussion, exchange of ideas, and joint research.

There are two issues that inevitably become important when materials science deals with medical science and medicine, which are related to human life. The first is that basic research is extremely important in order to proceed with this research in a truly efficient manner, since it is a completely new endeavor that has never been attempted before. By properly clarifying the mechanism, it will be possible to systematically address a wide range of complex issues and to conduct research in a predictive manner. In particular, safety is an extremely important issue, and it is highly desirable to be based on principles. Another issue is the distribution of the resulting results.

Although nanomedicine research has great potential to develop cures for intractable diseases that could not be solved in the past, the fact that only a few wealthy people can benefit from it is a contradiction in terms of nanotechnology being an intellectual asset for mankind. Considering that such inequity is occurring on a global scale, it is extremely important that nanomedicine research be conducted through international collaboration. We aim to contribute to the development of science and medical technology and the training of young researchers in the Asian region through the exchange of researchers and medical professionals involved in nanomedicine from basic to applied fields around the world.

Added in June 2020

It has been nearly 17 years since the term “nanomedicine” was coined, but the pandemics that have frequently struck humanity in recent years and the many intractable diseases whose misery is becoming more and more pronounced strongly suggest the need to put the achievements of basic science, iPS cell technology, genome editing, etc. of the past 20 years to practical use. Nanomedicine needs to be promoted more deeply and strongly under close international collaboration.

 

 

Outline

Name

Japan nanomedicine Society: JNS

President

Hideo Higuchi (2024- Present)

Tsuneo Urisu (2006-2023)

Business Activities

  1. International Conference on Nanomedicine
  2. Publication of Newsletters
  3. Liaison and collaboration with related domestic and international academic organizations
  4. Awards for outstanding performance
  5. Other activities necessary to achieve the objectives of the Society

Number of Members

150 persons

Secretariat office

Secretariat of Japan Nanomedicine Society

6-6-10 Aoba, Aramaki-aza, Aoba-ku, Sendai, Miyagi 980-8579, Japan
New Industry Creation Hatchery Center, Tohoku University
Tel:022-795-4184
Email:hideo.higuchi.d6(at)tohoku.ac.jp 

Replace (at) with @.

History

April 2001

Nano Reaction Field and Bioelectronics Control Research Group

March 2005

1st Molecular-Based Information Transmission and Reception-MB-ITR2005, Okazaki

February 2006: Founded Japan Nanomedicine Society

The 1st Nanomedicine Symposium, Okazaki

April 2007

1st International Symposium on Nanomedicine
-from Basic to Applications- (ISNM2007),
2nd Molecular-Based Information Transmission and Reception, Okazaki

March 2008

2nd Steering Committee Meeting, Kyoto University Tokyo Liaison Office (Sapia Tower)

February 2009

2nd International Symposium on Nanomedicine
Asian Core Symposium -Nano and Biomedical Molecular Science-, Okazaki